Bioethics, Ltd.
BOTH
$1.25
$0.70127.27%
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 103.10K | 73.80K | 65.60K | 50.40K | 45.70K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 103.10K | 73.80K | 65.60K | 50.40K | 45.70K |
| Operating Income | -103.10K | -73.80K | -65.60K | -50.40K | -45.70K |
| Income Before Tax | -153.10K | -122.30K | -113.20K | -97.10K | -93.40K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -0.15 | -0.12 | -0.11 | -0.10 | -0.09 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -153.10K | -122.30K | -113.20K | -97.10K | -93.40K |
| EBIT | -103.10K | -73.80K | -65.60K | -50.40K | -45.70K |
| EBITDA | -- | -- | -- | -- | -8.80K |
| EPS Basic | -0.13 | -0.11 | -0.10 | -0.09 | -0.08 |
| Normalized Basic EPS | -0.08 | -0.07 | -0.06 | -0.05 | -0.05 |
| EPS Diluted | -0.13 | -0.11 | -0.10 | -0.09 | -0.08 |
| Normalized Diluted EPS | -0.08 | -0.07 | -0.06 | -0.05 | -0.05 |
| Average Basic Shares Outstanding | 4.54M | 4.54M | 4.54M | 4.54M | 4.54M |
| Average Diluted Shares Outstanding | 4.54M | 4.54M | 4.54M | 4.54M | 4.54M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |